Correlation Between Seres Therapeutics and Check Point
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Check Point at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Check Point into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Check Point Software, you can compare the effects of market volatilities on Seres Therapeutics and Check Point and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Check Point. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Check Point.
Diversification Opportunities for Seres Therapeutics and Check Point
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Seres and Check is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Check Point Software in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Check Point Software and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Check Point. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Check Point Software has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Check Point go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Check Point
Assuming the 90 days horizon Seres Therapeutics is expected to under-perform the Check Point. In addition to that, Seres Therapeutics is 4.77 times more volatile than Check Point Software. It trades about -0.01 of its total potential returns per unit of risk. Check Point Software is currently generating about 0.06 per unit of volatility. If you would invest 12,142 in Check Point Software on October 9, 2024 and sell it today you would earn a total of 5,218 from holding Check Point Software or generate 42.97% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Seres Therapeutics vs. Check Point Software
Performance |
| Timeline |
| Seres Therapeutics |
| Check Point Software |
Seres Therapeutics and Check Point Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Seres Therapeutics and Check Point
The main advantage of trading using opposite Seres Therapeutics and Check Point positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Check Point can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Check Point will offset losses from the drop in Check Point's long position.| Seres Therapeutics vs. United Insurance Holdings | Seres Therapeutics vs. InterContinental Hotels Group | Seres Therapeutics vs. Choice Hotels International | Seres Therapeutics vs. UmweltBank AG |
| Check Point vs. alstria office REIT AG | Check Point vs. NorAm Drilling AS | Check Point vs. Richardson Electronics | Check Point vs. Major Drilling Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |